Find Arginine Vasopressin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

GLOBAL SALES INFORMATION

US Medicaid

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Arginine vasopressin, 113-79-1, Argipressine, Pitressin, Beta-hypophamine, 8-arginine-vasopressin
Molecular Formula
C46H65N15O12S2
Molecular Weight
1084.2  g/mol
InChI Key
KBZOIRJILGZLEJ-LGYYRGKSSA-N

Arginine Vasopressin
The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE.
1 2D Structure

Arginine Vasopressin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pyrrolidine-2-carboxamide
2.1.2 InChI
InChI=1S/C46H65N15O12S2/c47-27-22-74-75-23-33(45(73)61-17-5-9-34(61)44(72)56-28(8-4-16-53-46(51)52)39(67)54-21-37(50)65)60-43(71)32(20-36(49)64)59-40(68)29(14-15-35(48)63)55-41(69)31(18-24-6-2-1-3-7-24)58-42(70)30(57-38(27)66)19-25-10-12-26(62)13-11-25/h1-3,6-7,10-13,27-34,62H,4-5,8-9,14-23,47H2,(H2,48,63)(H2,49,64)(H2,50,65)(H,54,67)(H,55,69)(H,56,72)(H,57,66)(H,58,70)(H,59,68)(H,60,71)(H4,51,52,53)/t27-,28-,29-,30-,31-,32-,33-,34-/m0/s1
2.1.3 InChI Key
KBZOIRJILGZLEJ-LGYYRGKSSA-N
2.1.4 Canonical SMILES
C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
2.1.5 Isomeric SMILES
C1C[C@H](N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N
2.2 Synonyms
2.2.1 MeSH Synonyms

1. Arg Vasopressin

2. Arg-vasopressin

3. Arginine Vasopressin

4. Argipressin Tannate

5. Vasopressin, Arginine

2.2.2 Depositor-Supplied Synonyms

1. Arginine Vasopressin

2. 113-79-1

3. Argipressine

4. Pitressin

5. Beta-hypophamine

6. 8-arginine-vasopressin

7. Argipressin Tannate

8. Vasopressin (arginine Form)

9. Arginine-vasopressin

10. Chebi:34543

11. Vasophysin

12. Arg-vasopressin

13. Chembl373742

14. (arg8)-vasopressin

15. [arg8]-vasopressin

16. (2s)-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-n-[(2s)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pyrrolidine-2-carboxamide

17. 8-l-arginine Vasopressin

18. Argipresina

19. Argipressina

20. Argipressinum

21. Avp

22. Arg8-vasopressin

23. Argipressin [inn]

24. Argipressina [dcit]

25. Ncgc00166306-01

26. Argipressin [inn:ban]

27. 8-l-arginine-vasopressin

28. Argipresina [inn-spanish]

29. Argipressine [inn-french]

30. Argipressinum [inn-latin]

31. Unii-y4907o6mfd

32. Rindervasopressin

33. [3h]vasopressin

34. Einecs 204-035-4

35. 3-(phenylalanine)-8-arginineoxytocin

36. Arg8-vasopressin;avp

37. Arginine-8-vasopressin

38. Argipressin Or Lypressin

39. [8-arginine]vasopressin

40. [3h]argipressin Tannate

41. Antidiuretic Hormone (adh)

42. Arginine Vasopressin (avp)

43. Argipressin Tannate [usan]

44. Arginine Antidiuretic Hormone

45. Dsstox_cid_28324

46. Dsstox_rid_82752

47. Dsstox_gsid_48349

48. Schembl43139

49. Vasopressin, 8-l-arginine-

50. [cyclo S-s]cyfqncprg-nh2

51. Gtpl2168

52. Y4907o6mfd

53. Dtxsid0048349

54. Schembl17874853

55. Bdbm35667

56. Tox21_113037

57. Bdbm50044777

58. Mfcd00076738

59. Ncgc00166306-02

60. Ncgc00188439-01

61. Cas-113-79-1

62. H-cys-tyr-phe-gln-asn-cys-pro-arg-gly-nh2

63. Oxytocin, 3-(l-phenylalanine)-8-l-arginine-

64. Vasopressin, 8-l-arginine- (7ci,8ci,9ci)

65. Roxybenzyl-6,9,12,15,18-pentaoxo- (6ci)

66. 113a791

67. Q183011

68. Cys-tyr-phe-gln-asn-cys-pro-arg-gly-nh2[disulfide Bridge: 1-6]

69. (2s)-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-n-[(2s)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pyrrolidine-2-carboxamide

70. 1,2-dithia-5,8,11,14,17-pentaazacycloeicosane-10-propionamide, 19-amino-13-benzyl-7-(carbamoylmethyl)-4-[2-[[1-[(carbamoylmethyl)carbamoyl]-4-guanidinobutyl]carbamoyl]-1-pyrrolidinylcarbonyl]-16-p-hyd

71. 1-{[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-l-prolyl-l-arginylglycinamide

72. Glycinamide, L-cysteinyl-l-tyrosyl-l-phenylalanyl-l-glutaminyl-l-asparaginyl-l-cysteinyl-l-prolyl-l-arginyl-, Cyclic (1>6)-disulfide

2.3 Create Date
2005-06-01
3 Chemical and Physical Properties
Molecular Weight 1084.2 g/mol
Molecular Formula C46H65N15O12S2
XLogP3-4.8
Hydrogen Bond Donor Count14
Hydrogen Bond Acceptor Count16
Rotatable Bond Count19
Exact Mass1083.43785492 g/mol
Monoisotopic Mass1083.43785492 g/mol
Topological Polar Surface Area515 Ų
Heavy Atom Count75
Formal Charge0
Complexity2070
Isotope Atom Count0
Defined Atom Stereocenter Count8
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Vasoconstrictor Agents

Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)


Antidiuretic Agents

Agents that reduce the excretion of URINE, most notably the octapeptide VASOPRESSINS. (See all compounds classified as Antidiuretic Agents.)


Hemostatics

Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)


API SUPPLIERS

read-more
read-more

01

Aspen API

Netherlands

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAspen API. More than just an API™

Flag Netherlands
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
Aspen API Comapny Banner

02

Bachem AG

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Flag Switzerland
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
Bachem company banner

03

HRV Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF AU arrow-down AUDIT
HRV Global Life Sciences

04

Omgene Life Sciences Pvt. Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOmgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Omgene Company Banner

05

BCN Peptides

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BioJapan
Not Confirmed
arrow

BCN Peptides

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioJapan
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

06

Piramal Pharma Solutions

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BioJapan
Not Confirmed
arrow

Piramal Pharma Solutions

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioJapan
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

07

PolyPeptide Group

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BioJapan
Not Confirmed
arrow

PolyPeptide Group

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioJapan
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

08

Auro Peptides Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BioJapan
Not Confirmed
arrow

Auro Peptides Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioJapan
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
blank

09

Hainan Shuangcheng Pharmaceuticals

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BioJapan
Not Confirmed
arrow

Hainan Shuangcheng Pharmaceuticals

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioJapan
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

Pfizer Inc

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BioJapan
Not Confirmed
arrow

Pfizer Inc

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BioJapan
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

Bachem Americas Inc

Switzerland
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Flag Switzerland
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2017-09-29

Pay. Date : 2017-08-24

DMF Number : 28532

Submission : 2014-08-01

Status : Active

Type : II

Bachem company banner

02

The Battery Show
Not Confirmed

02

The Battery Show
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2018-07-13

Pay. Date : 2018-05-04

DMF Number : 32769

Submission : 2018-05-05

Status : Active

Type : II

blank

03

Auro Peptides Ltd

India

USDMF

arrow
The Battery Show
Not Confirmed

03

The Battery Show
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2018-09-11

Pay. Date : 2018-08-27

DMF Number : 33119

Submission : 2018-08-27

Status : Active

Type : II

blank

04

Bcn Peptides Sa

Spain

USDMF

arrow
The Battery Show
Not Confirmed

04

The Battery Show
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 25736

Submission : 2012-01-24

Status : Active

Type : II

blank

05

The Battery Show
Not Confirmed

05

The Battery Show
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2023-01-19

Pay. Date : 2022-11-25

DMF Number : 37634

Submission : 2022-12-03

Status : Active

Type : II

blank

06

Hetero Drugs Ltd

India

USDMF

arrow
The Battery Show
Not Confirmed

06

The Battery Show
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2025-07-25

Pay. Date : 2025-07-15

DMF Number : 42073

Submission : 2025-06-30

Status : Active

Type : II

blank

07

The Battery Show
Not Confirmed

08

Piramal Pharma Ltd

U.S.A

USDMF

arrow
The Battery Show
Not Confirmed

08

The Battery Show
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2018-03-06

Pay. Date : 2017-11-27

DMF Number : 32146

Submission : 2017-10-12

Status : Active

Type : II

blank

09

The Battery Show
Not Confirmed

09

The Battery Show
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2018-03-02

Pay. Date : 2017-10-04

DMF Number : 32116

Submission : 2017-10-03

Status : Active

Type : II

blank

10

The Battery Show
Not Confirmed

10

The Battery Show
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 27577

Submission : 2013-12-19

Status : Inactive

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-moreread-more

01

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

Vasopressin USP

Date of Issue : 2025-10-01

Valid Till : 2028-06-10

Written Confirmation Number : WC-0443

Address of the Firm : 4th Floor, Survey No. 71 & 72,Indrakaran (Village), Kandi (Mandal), Sangareddy (...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

Aspen Oss B.V.

Netherlands
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAspen API. More than just an API™

Flag Netherlands
Digital Content Digital Content

ARGIPRESSIN

NDC Package Code : 60870-0277

Start Marketing Date : 1980-04-25

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

Aspen API Comapny Banner

02

Bachem Americas, Inc.

Switzerland
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Flag Switzerland
Digital Content Digital Content

VASOPRESSIN

NDC Package Code : 52416-127

Start Marketing Date : 2019-05-16

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

Bachem company banner

03

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

VASOPRESSIN, UNSPECIFIED

NDC Package Code : 41701-008

Start Marketing Date : 2016-03-28

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1.83g/1.83g)

Marketing Category : BULK INGREDIENT

blank

04

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

VASOPRESSIN, UNSPECIFIED

NDC Package Code : 41701-008

Start Marketing Date : 2016-03-28

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (0.5g/.5g)

Marketing Category : BULK INGREDIENT

blank

05

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

VASOPRESSIN, UNSPECIFIED

NDC Package Code : 41701-008

Start Marketing Date : 2016-03-28

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank

06

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

VASOPRESSIN, UNSPECIFIED

NDC Package Code : 41701-008

Start Marketing Date : 2016-03-28

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (0.8g/.8g)

Marketing Category : BULK INGREDIENT

blank

07

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

VASOPRESSIN, UNSPECIFIED

NDC Package Code : 41701-008

Start Marketing Date : 2016-03-28

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (3g/3g)

Marketing Category : BULK INGREDIENT

blank

08

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

VASOPRESSIN, UNSPECIFIED

NDC Package Code : 41701-008

Start Marketing Date : 2016-03-28

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (3.35g/3.35g)

Marketing Category : BULK INGREDIENT

blank

09

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

VASOPRESSIN, UNSPECIFIED

NDC Package Code : 41701-008

Start Marketing Date : 2016-03-28

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1.73g/1.73g)

Marketing Category : BULK INGREDIENT

blank

10

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

VASOPRESSIN

NDC Package Code : 63586-0004

Start Marketing Date : 2023-01-02

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (100g/100g)

Marketing Category : BULK INGREDIENT

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

HRV Pharma

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content

Vasopressin Acetate

About the Company : HRV Pharma is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...

HRV Pharma is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It offers services such as sourcing, manufacturing & supply, helping partners enter new markets worldwide. Its strong partnerships with major players in the pharma and food additive industries help HRV Pharma effectively promote projects and products. HRV Pharma represents over 30 large Indian drugmakers, primarily targeting Europe, the US & the Middle East markets. Headquartered in India, HRV Pharma has offices in the US, Switzerland, Dubai, Lithuania & Turkey.
HRV Global Life Sciences

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOmgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Flag India
Digital Content Digital Content

Vasopressin

About the Company : Omgene Life Sciences Private Limited is an R&D-driven biopharmaceutical company specializing in biopharmaceuticals, peptides, semi-synthetic, and synthetic actives. As a vertically...

Omgene Life Sciences Private Limited is an R&D-driven biopharmaceutical company specializing in biopharmaceuticals, peptides, semi-synthetic, and synthetic actives. As a vertically integrated company, we focus on developing high-quality formulations based on in-house-produced actives. With GMP-certified facilities and partnerships with contract manufacturers, we excel in formulation development for injectables, lyophilized injectables, complex generics, and oral peptide delivery systems, ensuring affordable, top-quality medicines.
Omgene Company Banner

03

Apicore

India
The Battery Show
Not Confirmed
arrow

Apicore

India
arrow
The Battery Show
Not Confirmed

Arginine Vasopressin

About the Company : Apicore LLC, a wholly owned subsidiary of RK Pharma Inc is a leading process R&D and API manufacturing service provider for the worldwide pharmaceutical industry. We offer a wide p...

Apicore LLC, a wholly owned subsidiary of RK Pharma Inc is a leading process R&D and API manufacturing service provider for the worldwide pharmaceutical industry. We offer a wide portfolio of services ranging from API’s for the generic industry to custom synthesis for early phase pharmaceutical research and branded products. Our USFDA approved facilities in India (Visakhapatnam, Andhra Pradesh and Vadodara, Gujarat) are both equipped with state-of-the-art analytical and research capabilities. While our worldwide network of locations seamlessly integrate with each other, each unit also independently houses a full
blank

04

The Battery Show
Not Confirmed
arrow
arrow
The Battery Show
Not Confirmed

Arginine Vasopressin

About the Company : Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company comme...

Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others.
blank

05

BCN Peptides

Spain
The Battery Show
Not Confirmed
arrow

BCN Peptides

Spain
arrow
The Battery Show
Not Confirmed

Arginine Vasopressin

About the Company : BCN Peptides is a privately own company completely focused on the cGMP manufacture of Bioactive Peptides for Pharmaceutical and Veterinary applications. We are a customer oriented...

BCN Peptides is a privately own company completely focused on the cGMP manufacture of Bioactive Peptides for Pharmaceutical and Veterinary applications. We are a customer oriented organization focused on fulfilling the client’s needs at each stage of the their peptide drug development and lifecycle management. It also includes a team of dedicated and passionate scientists which help us to provide to our customer a scientific excellence in terms of synthetic peptide chemistry and analytical expertise. BCN Peptides has an excellent track record of successful inspections by Global Health Agencies (US FDA, EDQM, KFDA,…)
blank

06

The Battery Show
Not Confirmed
arrow
arrow
The Battery Show
Not Confirmed

Arginine Vasopressin

About the Company : JIN DUN Medical Research Institute is affiliated to Shanghai JIN DUN Industrial Co., Ltd., headquartered in Shanghai, adjacent to Hongqiao High-speed Railway Station and Hongqiao I...

JIN DUN Medical Research Institute is affiliated to Shanghai JIN DUN Industrial Co., Ltd., headquartered in Shanghai, adjacent to Hongqiao High-speed Railway Station and Hongqiao International airport. JIN DUN Medical Research Institute is committed to providing pharmaceutical intermediates and raw materials with the purpose of innovative drug research. Customized R&D and customized production services.
blank

07

The Battery Show
Not Confirmed
arrow
arrow
The Battery Show
Not Confirmed

Arginine Vasopressin

About the Company : Consistent growth and sustainability is a multidimensional aspiration for all at Macleods, we remained focused on providing quality and affordable medicines to billions of ailing p...

Consistent growth and sustainability is a multidimensional aspiration for all at Macleods, we remained focused on providing quality and affordable medicines to billions of ailing patients across geographies and bridging the gap of unmet needs of medical fraternity through continuous innovation. Our basic business philosophy, by its very nature, serves a social responsibility hence we have a far better reason than profits alone to drive our performance. Sustainability, is not a trend we blindly follow, it is intrinsic to how we have operated since the genesis of the organization in the year 1986.
blank

08

The Battery Show
Not Confirmed
arrow
arrow
The Battery Show
Not Confirmed

Arginine Vasopressin

About the Company : Piramal Pharma Solutions (PPS) is a CDMO that provides end-to-end solutions for drug development and manufacturing across the drug life cycle to its clients in North America, Europ...

Piramal Pharma Solutions (PPS) is a CDMO that provides end-to-end solutions for drug development and manufacturing across the drug life cycle to its clients in North America, Europe and Asia through a globally integrated network of facilities. It offers a range of services from drug discovery to commercial supply of APIs and finished dosage forms, along with specialized services like HPAPIs, antibody drug conjugations, sterile fill/finish, peptide products and services and potent solid oral drug products. PPS also provides services for biologics, including vaccines, gene therapies and monoclonal antibodies through its subsidiary Yapan Bio.
blank

09

The Battery Show
Not Confirmed
arrow
arrow
The Battery Show
Not Confirmed

Arginine Vasopressin

About the Company : Shenzhen JYMed Technology Co.,Ltd is a high-tech enterprise engaged in research and development, manufacturing and commercialization of peptides based products, including active ph...

Shenzhen JYMed Technology Co.,Ltd is a high-tech enterprise engaged in research and development, manufacturing and commercialization of peptides based products, including active pharmaceutical ingredient peptides, cosmetic peptides, and custom peptides as well other new drug development. We strive for continuing innovations in new peptide synthesis technology and process optimization, and our technical team have over decade of experience in peptide synthesis. Our peptide plant is located in Nanjing, Jiangsu province and it has set up a facility of 30,000 square meters in compliance with cGMP guideline.
blank

10

The Battery Show
Not Confirmed
arrow
arrow
The Battery Show
Not Confirmed

Vasopressin

About the Company : With over a decade of experience in the Pharmaceutical and Health sector, HNB stands as a contemporary company specializing in the exploration, advancement, manufacturing, processi...

With over a decade of experience in the Pharmaceutical and Health sector, HNB stands as a contemporary company specializing in the exploration, advancement, manufacturing, processing, and global exportation of Active Pharmaceutical Ingredients (API), diverse additives encompassing those for food, feed, and cosmetics, a range of hormone products, and other related items since the year 2007.We pride ourselves on being your premier supplier, offering a wider array and the utmost quality in products. Our primary offerings include API, assorted additive products, and select Polypeptide Hormones.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1665772200,"product":"VASOPRESSIN","address":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER","city":"PAREL MUMBAI MAHARASHTRA,MAHARASHTR","supplier":"CIPLA LTD","supplierCountry":"INDIA","foreign_port":"FAJARDO","customer":"PALL LIFE SCIENCE PR LLC","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.08","unit":"GMS","unitRateFc":"202291.8","totalValueFC":"194.4","currency":"INR","unitRateINR":200000,"date":"15-Oct-2022","totalValueINR":"16000","totalValueInUsd":"194.4","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"4838049","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER, PAREL MUMBAI MAHARASHTRA,MAHARASHTR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1709490600,"product":"VASOPRESSIN USP 2023 POWDER (SYNTHETIC) (QTY: 1 GRAM)","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"DUBAI","customer":"BAKHT AL AZHAR TRADING LLC","customerCountry":"UNITED ARAB EMIRATES","quantity":"0.00","actualQuantity":"1","unit":"GMS","unitRateFc":"9407.6","totalValueFC":"2339.6","currency":"AED","unitRateINR":194270.67000000001,"date":"04-Mar-2024","totalValueINR":"194270.67","totalValueInUsd":"2339.6","indian_port":"Bombay Air","hs_no":"29371900","bill_no":"8035007","productDescription":"API","marketType":"","country":"UNITED ARAB EMIRATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711737000,"product":"N-ACETYLVASOPRESSIN(QTY:50 MG)(PHARMA STANDARDS)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"WASHINGTON, DULLES I","customer":"ATTN LISA GOSSETT","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.05","unit":"GMS","unitRateFc":"30000","totalValueFC":"1242.8","currency":"USD","unitRateINR":2063894.8,"date":"30-Mar-2024","totalValueINR":"103194.74","totalValueInUsd":"1242.8","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"8762834","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, ","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711737000,"product":"VASOPRESSIN PARALLEL DIMER(QTY:50 MG)(PHARMA STANDARDS)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"WASHINGTON, DULLES I","customer":"ATTN LISA GOSSETT","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.05","unit":"GMS","unitRateFc":"54000","totalValueFC":"2237","currency":"USD","unitRateINR":3715009.3999999999,"date":"30-Mar-2024","totalValueINR":"185750.47","totalValueInUsd":"2237","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"8762834","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, ","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1722277800,"product":"(ASP)5-VASOPRESSIN(PHARM STANDS)(QTY: 8GMS)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"WASHINGTON, DULLES I","customer":"ATTNROSHIE BANISADR","customerCountry":"UNITED STATES","quantity":"0.01","actualQuantity":"8","unit":"GMS","unitRateFc":"3150","totalValueFC":"24961.5","currency":"USD","unitRateINR":260820.01749999999,"date":"30-Jul-2024","totalValueINR":"2086560.14","totalValueInUsd":"24961.5","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"2819521","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1724437800,"product":"AC-VASOPRESSIN(QTY:25 MG)(PHARMA STANDS)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"WASHINGTON, DULLES I","customer":"ATTN SRINIVASA PIPPALLA","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.025","unit":"GMS","unitRateFc":"36000","totalValueFC":"589.9","currency":"USD","unitRateINR":1979057.9999999998,"date":"24-Aug-2024","totalValueINR":"49476.45","totalValueInUsd":"589.9","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"3461153","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1724437800,"product":"D-ASN(5)-VASOPRESSIN(QTY:25 MG)(PHARMA STANDS)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"WASHINGTON, DULLES I","customer":"ATTN SRINIVASA PIPPALLA","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.025","unit":"GMS","unitRateFc":"40000","totalValueFC":"655.4","currency":"USD","unitRateINR":2198954.3999999999,"date":"24-Aug-2024","totalValueINR":"54973.86","totalValueInUsd":"655.4","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"3461153","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1724437800,"product":"PARALLEL DIMER-VASOPRESSIN(QTY:25 MG)(PHARMA STANDS)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"WASHINGTON, DULLES I","customer":"ATTN SRINIVASA PIPPALLA","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.025","unit":"GMS","unitRateFc":"68000","totalValueFC":"1114.2","currency":"USD","unitRateINR":3738222,"date":"24-Aug-2024","totalValueINR":"93455.55","totalValueInUsd":"1114.2","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"3461153","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725215400,"product":"PHARMA STANDARDS: D-ASN(5)-VASOPRESSIN (R & D PURPOSE ONLY)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"AMMAN","customer":"HIKMA PHARMACEUTICALS","customerCountry":"JORDAN","quantity":"0.00","actualQuantity":"0.025","unit":"GMS","unitRateFc":"32800","totalValueFC":"647.5","currency":"USD","unitRateINR":2170449.5999999996,"date":"02-Sep-2024","totalValueINR":"54261.24","totalValueInUsd":"647.5","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"3682655","productDescription":"API","marketType":"","country":"JORDAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725215400,"product":"PHARMA STANDARDS: PARALLEL DIMEMR-VASOPRESSIN (R & D PURPOSE ONLY)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"AMMAN","customer":"HIKMA PHARMACEUTICALS","customerCountry":"JORDAN","quantity":"0.00","actualQuantity":"0.025","unit":"GMS","unitRateFc":"56800","totalValueFC":"1121.3","currency":"USD","unitRateINR":3758582.8000000003,"date":"02-Sep-2024","totalValueINR":"93964.57","totalValueInUsd":"1121.3","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"3682655","productDescription":"API","marketType":"","country":"JORDAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1729881000,"product":"ACETYL-VASOPRESSIN(PHARMA STANDARDS)(QTY:50 MGS X 1 VIAL)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"WASHINGTON, DULLES I","customer":"ATTNSRINIVASA PIPPALLA","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.05","unit":"GMS","unitRateFc":"30160","totalValueFC":"1251.9","currency":"USD","unitRateINR":2103877.9999999995,"date":"26-Oct-2024","totalValueINR":"105193.9","totalValueInUsd":"1251.9","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"5163208","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1729881000,"product":"ASP5-VASOPRESSIN(PHARMA STANDARDS)(QTY:50 MGS X 1 VIAL)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"WASHINGTON, DULLES I","customer":"ATTNSRINIVASA PIPPALLA","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.05","unit":"GMS","unitRateFc":"30160","totalValueFC":"1251.9","currency":"USD","unitRateINR":2103877.9999999995,"date":"26-Oct-2024","totalValueINR":"105193.9","totalValueInUsd":"1251.9","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"5163208","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1729881000,"product":"D-ASN5-VASOPRESSIN(PHARMA STANDARDS)(QTY:50 MGS X 1 VIAL)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"WASHINGTON, DULLES I","customer":"ATTNSRINIVASA PIPPALLA","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.05","unit":"GMS","unitRateFc":"30160","totalValueFC":"1251.9","currency":"USD","unitRateINR":2103877.9999999995,"date":"26-Oct-2024","totalValueINR":"105193.9","totalValueInUsd":"1251.9","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"5163208","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1731263400,"product":"ANTIPARALLEL DIMER-VASOPRESSIN(50 MG X 3VIALS)(QTY:150 MG)(PHARMA STANDARDS)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"AMMAN","customer":"HIKMA PHARMACEUTICALS PLC","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.15","unit":"GMS","unitRateFc":"24666.7","totalValueFC":"3394.4","currency":"USD","unitRateINR":1909631.2,"date":"11-Nov-2024","totalValueINR":"286444.68","totalValueInUsd":"3394.4","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"5506045","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1731263400,"product":"PARALLEL DIMER-VASOPRESSIN(50 MG X 3 VIALS)(QTY:150 MG)(PHARMA STANDARDS)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"AMMAN","customer":"HIKMA PHARMACEUTICALS PLC","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.15","unit":"GMS","unitRateFc":"20000","totalValueFC":"2752.2","currency":"USD","unitRateINR":1548349.4666666668,"date":"11-Nov-2024","totalValueINR":"232252.42","totalValueInUsd":"2752.2","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"5506045","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1732559400,"product":"DES-GLY-VASOPRESSIN(50 MG X 1 VIAL)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"AMMAN","customer":"HIKMA PHARMACEUTICALS PLC","customerCountry":"JORDAN","quantity":"0.00","actualQuantity":"0.05","unit":"GMS","unitRateFc":"25000","totalValueFC":"842.1","currency":"USD","unitRateINR":1421199.8,"date":"26-Nov-2024","totalValueINR":"71059.99","totalValueInUsd":"842.1","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"5908208","productDescription":"API","marketType":"","country":"JORDAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1732559400,"product":"DES-GLY-VASOPRESSIN(50 MG X 1 VIAL)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"AMMAN","customer":"HIKMA PHARMACEUTICALS PLC","customerCountry":"JORDAN","quantity":"0.00","actualQuantity":"0.05","unit":"GMS","unitRateFc":"25000","totalValueFC":"1238.3","currency":"USD","unitRateINR":2089999.8,"date":"26-Nov-2024","totalValueINR":"104499.99","totalValueInUsd":"1238.3","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"5911440","productDescription":"API","marketType":"","country":"JORDAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1732559400,"product":"ENDO-GLY-VASOPRESSIN(50 MG X 1 VIAL)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"AMMAN","customer":"HIKMA PHARMACEUTICALS PLC","customerCountry":"JORDAN","quantity":"0.00","actualQuantity":"0.05","unit":"GMS","unitRateFc":"25000","totalValueFC":"1238.3","currency":"USD","unitRateINR":2089999.8,"date":"26-Nov-2024","totalValueINR":"104499.99","totalValueInUsd":"1238.3","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"5911440","productDescription":"API","marketType":"","country":"JORDAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1732818600,"product":"ENDO-GLY-VASOPRESSIN(50 MG X 1 VIAL)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LISBON","customer":"HIKMA PHARMACEUTICA PORTUGA S A","customerCountry":"PORTUGAL","quantity":"0.00","actualQuantity":"0.05","unit":"GMS","unitRateFc":"25000","totalValueFC":"1238.3","currency":"USD","unitRateINR":2089999.8,"date":"29-Nov-2024","totalValueINR":"104499.99","totalValueInUsd":"1238.3","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"6008516","productDescription":"API","marketType":"REGULATED MARKET","country":"PORTUGAL","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1732818600,"product":"N-ACETYL-VASOPRESSIN(50 MG X 1 VIAL)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LISBON","customer":"HIKMA PHARMACEUTICA PORTUGA S A","customerCountry":"PORTUGAL","quantity":"0.00","actualQuantity":"0.05","unit":"GMS","unitRateFc":"25000","totalValueFC":"1238.3","currency":"USD","unitRateINR":2089999.8,"date":"29-Nov-2024","totalValueINR":"104499.99","totalValueInUsd":"1238.3","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"6008516","productDescription":"API","marketType":"REGULATED MARKET","country":"PORTUGAL","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1733077800,"product":"CYS1(S2)VASOPRESSIN","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"DETROIT WAYNE COUNT","customer":"CHIRAL TECHNOLOGIES INC","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.075","unit":"GMS","unitRateFc":"15750","totalValueFC":"1162.2","currency":"USD","unitRateINR":1316700,"date":"02-Dec-2024","totalValueINR":"98752.5","totalValueInUsd":"1162.2","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"6083217","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1733077800,"product":"D-ASN-VASOPRESSIN","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"DETROIT WAYNE COUNT","customer":"CHIRAL TECHNOLOGIES INC","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.01","unit":"GMS","unitRateFc":"84000","totalValueFC":"826.5","currency":"USD","unitRateINR":7022402,"date":"02-Dec-2024","totalValueINR":"70224.02","totalValueInUsd":"826.5","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"6083217","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1733077800,"product":"DES-PRO(7)-VASOPRESSIN","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"DETROIT WAYNE COUNT","customer":"CHIRAL TECHNOLOGIES INC","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.01","unit":"GMS","unitRateFc":"84000","totalValueFC":"826.5","currency":"USD","unitRateINR":7022402,"date":"02-Dec-2024","totalValueINR":"70224.02","totalValueInUsd":"826.5","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"6083217","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1733077800,"product":"GLU4-VASOPRESSIN1","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"DETROIT WAYNE COUNT","customer":"CHIRAL TECHNOLOGIES INC","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.01","unit":"GMS","unitRateFc":"84000","totalValueFC":"826.5","currency":"USD","unitRateINR":7022402,"date":"02-Dec-2024","totalValueINR":"70224.02","totalValueInUsd":"826.5","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"6083217","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1733423400,"product":"PARALLEL DIMER VASOPRESSIN(QTY:50 MG)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"VIENNA","customer":"ATTNMARTINA KNAPP","customerCountry":"AUSTRIA","quantity":"0.00","actualQuantity":"0.05","unit":"GMS","unitRateFc":"79000","totalValueFC":"2715.4","currency":"USD","unitRateINR":4614500,"date":"06-Dec-2024","totalValueINR":"230725","totalValueInUsd":"2715.4","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"6215044","productDescription":"API","marketType":"REGULATED MARKET","country":"AUSTRIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1738348200,"product":"GLY-OH VASOPRESSIN (50 MG X 1 VIAL)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LISBON","customer":"HIKMA PHARMACEUTICA","customerCountry":"PORTUGAL","quantity":"0.00","actualQuantity":"0.05","unit":"GMS","unitRateFc":"16000","totalValueFC":"785.6","currency":"USD","unitRateINR":1366400,"date":"01-Feb-2025","totalValueINR":"68320","totalValueInUsd":"785.6","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"7796779","productDescription":"API","marketType":"REGULATED MARKET","country":"PORTUGAL","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1739989800,"product":"GLY-OH VASOPRESSIN(50 MG X 1 VIALS)(QTY:50 MG)(PHARMA STANDARDS)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"AMMAN","customer":"HIKMA PHARMACEUTICALS PLC","customerCountry":"JORDAN","quantity":"0.00","actualQuantity":"0.05","unit":"GMS","unitRateFc":"20000","totalValueFC":"849.3","currency":"USD","unitRateINR":1477111.2,"date":"20-Feb-2025","totalValueINR":"73855.56","totalValueInUsd":"849.3","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"8357280","productDescription":"API","marketType":"","country":"JORDAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1742495400,"product":"VASOPRESSIN USP POWDER (SYNTHETIC) INV.EX\/TU\/2425\/00229","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"CHICAGO, IL","customer":"HIKMA PHARMACEUTICALS USA INC","customerCountry":"UNITED STATES","quantity":"0.01","actualQuantity":"9","unit":"GMS","unitRateFc":"1500","totalValueFC":"11447.3","currency":"USD","unitRateINR":110170.66666666667,"date":"21-Mar-2025","totalValueINR":"991536","totalValueInUsd":"11447.3","indian_port":"Bombay Air","hs_no":"29371900","bill_no":"9198997","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1743445800,"product":"GLU(4)-GLY-OH-VASOPRESSIN(QTY:10 MG)(PHARMA STANDARDS)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"ZAGREB","customer":"HIKMA DOO","customerCountry":"CROATIA","quantity":"0.00","actualQuantity":"0.01","unit":"GMS","unitRateFc":"65000","totalValueFC":"513.1","currency":"USD","unitRateINR":4392632,"date":"01-Apr-2025","totalValueINR":"43926.32","totalValueInUsd":"513.1","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"9582366","productDescription":"API","marketType":"REGULATED MARKET","country":"CROATIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1743445800,"product":"VASOPRESSIN D5(QTY:10 MG)(PHARMA STANDARDS)","address":"LABORATORY,NO.4A,PHASE III, ICICI","city":"N\/A","supplier":"DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"ZAGREB","customer":"HIKMA DOO","customerCountry":"CROATIA","quantity":"0.00","actualQuantity":"0.01","unit":"GMS","unitRateFc":"180000","totalValueFC":"1421","currency":"USD","unitRateINR":12164212,"date":"01-Apr-2025","totalValueINR":"121642.12","totalValueInUsd":"1421","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"9582366","productDescription":"API","marketType":"REGULATED MARKET","country":"CROATIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"LABORATORY,NO.4A,PHASE III, ICICI, N\/A","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1650825000,"product":"VASOPRESSIN USP","address":"ALEMBIC ROAD VADODARA Contact No: 919727727339","city":"GUJARAT","supplier":"POLYPEPTIDE LABORATORIES SWEDEN AB","supplierCountry":"SWEDEN","foreign_port":"NA","customer":"ALEMBIC PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"0.04","actualQuantity":"40","unit":"GMS","unitRateFc":"3500","totalValueFC":"153997","currency":"USD","unitRateINR":"290472.8","date":"25-Apr-2022","totalValueINR":"11618911","totalValueInUsd":"153997","indian_port":"BOMBAY AIR","hs_no":"29371900","bill_no":"8415527","productDescription":"API","marketType":"REGULATED MARKET","country":"SWEDEN","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"ALEMBIC ROAD VADODARA Contact No: 919727727339"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1656873000,"product":"VASOPRESSIN USP SPEC1","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE,,","city":"HYDERABAD,TELANGANA","supplier":"POLYPEPTIDE LABORATORIES SWEDEN AB","supplierCountry":"DENMARK","foreign_port":"N\/A","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"0.03","actualQuantity":"30","unit":"GMS","unitRateFc":"2837","totalValueFC":"84503.6","currency":"USD","unitRateINR":"223981.2","date":"04-Jul-2022","totalValueINR":"6719435","totalValueInUsd":"84503.6","indian_port":"Vizag-EPZ\/SEZ","hs_no":"29371900","bill_no":"1000990","productDescription":"API","marketType":"REGULATED MARKET","country":"DENMARK","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"LIMHAMNSVAGEN 108-PO BOX 30089 SE-200 61 LIMHAMN SWEDEN SE","customerAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE,,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1657045800,"product":"VASOPRESSIN USP","address":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta","city":"HYDERABAD","supplier":"POLYPEPTIDE LABORATORIES SWEDEN AB","supplierCountry":"SWEDEN","foreign_port":"NA","customer":"HETERO LABS LTD","customerCountry":"INDIA","quantity":"0.01","actualQuantity":"0.01","unit":"KGS","unitRateFc":"3600000","totalValueFC":"36289.6","currency":"USD","unitRateINR":"288562250","date":"06-Jul-2022","totalValueINR":"2885622.5","totalValueInUsd":"36289.6","indian_port":"MADRAS AIR","hs_no":"29372200","bill_no":"9435725","productDescription":"API","marketType":"REGULATED MARKET","country":"SWEDEN","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1657737000,"product":"(FOC) - VASOPRESSIN, USP - 4077849 - 1000010090","address":"NO.54\/1, BOODIHAL,,NELAMANGALA,","city":"BENGALURU,KARNATAKA","supplier":"BACHEM AMERICAS INC","supplierCountry":"UNITED STATES","foreign_port":"NA","customer":"SOMERSET THERAPEUTICS LTD","customerCountry":"INDIA","quantity":"0.01","actualQuantity":"5","unit":"GMS","unitRateFc":"3605","totalValueFC":"18795.2","currency":"USD","unitRateINR":"298905.9","date":"14-Jul-2022","totalValueINR":"1494529.5","totalValueInUsd":"18795.2","indian_port":"BANGALORE AIR","hs_no":"29371900","bill_no":"9555003","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"NO.54\/1, BOODIHAL,,NELAMANGALA,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1657737000,"product":"(FOC) - VASOPRESSIN, USP - 4077849 - 1000010093","address":"NO.54\/1, BOODIHAL,,NELAMANGALA,","city":"BENGALURU,KARNATAKA","supplier":"BACHEM AMERICAS INC","supplierCountry":"UNITED STATES","foreign_port":"NA","customer":"SOMERSET THERAPEUTICS LTD","customerCountry":"INDIA","quantity":"0.01","actualQuantity":"5","unit":"GMS","unitRateFc":"3605","totalValueFC":"18795.2","currency":"USD","unitRateINR":"298905.9","date":"14-Jul-2022","totalValueINR":"1494529.5","totalValueInUsd":"18795.2","indian_port":"BANGALORE AIR","hs_no":"29371900","bill_no":"9555003","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"NO.54\/1, BOODIHAL,,NELAMANGALA,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1657823400,"product":"501738 VASOPRESSIN USP ( 2.00GM )( TEST LICENCE NO. TL\/NZ\/20\/000254 DT. 02.06.2020 ) ( R & D PURPOSE )","address":"208, OKHLA INDUSTRIAL ESTATE,,PHAS E III","city":"NEW DELHI,DELHI","supplier":"POLYPEPTIDE LABORATORIES","supplierCountry":"SWEDEN","foreign_port":"NA","customer":"MANKIND PHARMA LTD","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.002","unit":"KGS","unitRateFc":"4250000","totalValueFC":"9093.6","currency":"USD","unitRateINR":"361547500","date":"15-Jul-2022","totalValueINR":"723095","totalValueInUsd":"9093.6","indian_port":"DELHI AIR","hs_no":"29371900","bill_no":"9573104","productDescription":"API","marketType":"REGULATED MARKET","country":"SWEDEN","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"208, OKHLA INDUSTRIAL ESTATE,,PHAS E III"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1658341800,"product":"501738 VASOPRESSIN USP, BATCH NO:20-21-0011-01, 20-21-0012-01 (18 GMS)","address":"SURVEY NO.506, SACHANA KALYANPURA R TALUKA- KADI, PALLI, MEHSANA","city":"MEHSANA","supplier":"POLYPEPTIDE LABORATORIES SWEDEN AB","supplierCountry":"SWEDEN","foreign_port":"NA","customer":"AMNEAL INJECTABLES PRIVATE LTD","customerCountry":"INDIA","quantity":"0.02","actualQuantity":"0.018","unit":"KGS","unitRateFc":"2000000","totalValueFC":"36726.3","currency":"USD","unitRateINR":"162241388.9","date":"21-Jul-2022","totalValueINR":"2920345","totalValueInUsd":"36726.3","indian_port":"AHMEDABAD AIR","hs_no":"29371900","bill_no":"9648421","productDescription":"API","marketType":"REGULATED MARKET","country":"SWEDEN","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"SURVEY NO.506, SACHANA KALYANPURA R TALUKA- KADI, PALLI, MEHSANA"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1668364200,"product":"VASOPRESSIN, LOT NO:VP2202 (1 GMS), FOR ANALYTICAL TESTING PURPOSE ONLY","address":"Block No. 193 Part 211 Part, Xcelon Industrial Park,Chakde India Weigh","city":"Bridge Rd Vasana Chacharwadi Tal Sa","supplier":"BCN PEPTIDES","supplierCountry":"SPAIN","foreign_port":"NA","customer":"FTF PHARMA PRIVATE LTD","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.001","unit":"KGS","unitRateFc":"3000000","totalValueFC":"3052.8","currency":"EURO","unitRateINR":"249150000","date":"14-Nov-2022","totalValueINR":"249150","totalValueInUsd":"3052.8","indian_port":"AHMEDABAD AIR","hs_no":"29371900","bill_no":"3294197","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"Block No. 193 Part 211 Part, Xcelon Industrial Park,Chakde India Weigh"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1672425000,"product":"VASOPRESSIN USP","address":"882\/1-871, NEAR KANKAVATI ,VILLAGE-","city":"AHMEDABAD, GUJARAT","supplier":"POLYPEPTIDE LABORATORIES SWEDEN AB","supplierCountry":"DENMARK","foreign_port":"N\/A","customer":"AMNEAL PHARMACEUTICALS PVT LTD","customerCountry":"INDIA","quantity":"0.01","actualQuantity":"13","unit":"GMS","unitRateFc":"2000","totalValueFC":"26360.9","currency":"USD","unitRateINR":"167100","date":"31-Dec-2022","totalValueINR":"2172300","totalValueInUsd":"26360.9","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29371900","bill_no":"1005503","productDescription":"API","marketType":"REGULATED MARKET","country":"DENMARK","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"N\/A","customerAddress":"882\/1-871, NEAR KANKAVATI ,VILLAGE-"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1709490600,"product":"VASOPRESSIN API","address":"OLD NO.1\/63, NEW NO.1\/58 PUDUPAKKAM","city":"","supplier":"BCN PEPTIDES SAU","supplierCountry":"SPAIN","foreign_port":"BARCELONA","customer":"PAR FORMULATIONS PRIVATE LTD","customerCountry":"INDIA","quantity":"0.01","actualQuantity":"5","unit":"GMS","unitRateFc":"1500","totalValueFC":"7578.1","currency":"USD","unitRateINR":"125850","date":"04-Mar-2024","totalValueINR":"629250","totalValueInUsd":"7578.1","indian_port":"Bombay Air","hs_no":"29371900","bill_no":"2413275","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BARCELONA","supplierAddress":"POL. IND. ELS VINYETS-ELS FOGARS II08777 SANT QUINTI DE MEDIONA ,BARCELONA, SPAIN","customerAddress":"OLD NO.1\/63, NEW NO.1\/58 PUDUPAKKAM"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1716921000,"product":"VASOPRESSIN USP BATCH NO-20-23-0160-01 (25 GMS)","address":"882\/1-871, NEAR KANKAVATI ,VILLAGE-","city":"AHMEDABAD, GUJARAT","supplier":"POLYPEPTIDE LABORATORIES SWEDEN AB","supplierCountry":"SWEDEN","foreign_port":"COPENHAGEN","customer":"AMNEAL PHARMACEUTICALS PRIVATE LTD","customerCountry":"INDIA","quantity":"0.03","actualQuantity":"0.025","unit":"KGS","unitRateFc":"2250000","totalValueFC":"57478.6","currency":"USD","unitRateINR":"191643200","date":"29-May-2024","totalValueINR":"4791080","totalValueInUsd":"57478.6","indian_port":"Ahmedabad Air","hs_no":"29371900","bill_no":"3726372","productDescription":"API","marketType":"REGULATED MARKET","country":"SWEDEN","selfForZScoreResived":"Pharma Grade","supplierPort":"COPENHAGEN","supplierAddress":"LIMHAMNSVAGEN 108 PO BOX 30089- SE-200 61 LIMHAMN Limhamn, , SWEDENSDNF SWEDEN","customerAddress":"882\/1-871, NEAR KANKAVATI ,VILLAGE-"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1727029800,"product":"1,6,6,1 DIMER-VASOPRESSIN - ANTI PARALLEL DIMER VASOPRESSIN","address":"6-3-865\/1\/2, FLAT NO.201,","city":"HYDERABAD, ANDHRA PRADESH","supplier":"POLYPEPTIDE LABORATORIES SWEDEN AB","supplierCountry":"SWEDEN","foreign_port":"COPENHAGEN","customer":"GLAND PHARMA LTD","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.01","unit":"GMS","unitRateFc":"80000","totalValueFC":"807.6","currency":"USD","unitRateINR":"6768000","date":"23-Sep-2024","totalValueINR":"67680","totalValueInUsd":"807.6","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"5751812","productDescription":"API","marketType":"REGULATED MARKET","country":"SWEDEN","selfForZScoreResived":"Pharma Grade","supplierPort":"COPENHAGEN","supplierAddress":"LIMHAMNSVAGEN 108, PO BOX 30089 SE-200 61 LIMHAMN, SWEDEN REG. NO. 556389-7254 SE","customerAddress":"6-3-865\/1\/2, FLAT NO.201,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1728412200,"product":"VASOPRESSIN USP","address":"NO.18,DR NAIR ROAD, T NAGAR,","city":"CHENNAI","supplier":"POLYPEPTIDE LABORATORIES SWEDEN AB","supplierCountry":"SWEDEN","foreign_port":"COPENHAGEN","customer":"STERIL GENE LIFE SCIENCES PRIVATE LTD","customerCountry":"INDIA","quantity":"0.03","actualQuantity":"33","unit":"GMS","unitRateFc":"2250","totalValueFC":"75533","currency":"USD","unitRateINR":"192326.7","date":"09-Oct-2024","totalValueINR":"6346780","totalValueInUsd":"75533","indian_port":"Madras Air","hs_no":"29420090","bill_no":"6026335","productDescription":"API","marketType":"REGULATED MARKET","country":"SWEDEN","selfForZScoreResived":"Pharma Grade","supplierPort":"COPENHAGEN","supplierAddress":"LIMHAMNS VAGEN 108 PO BOX 30089 SE-200 61 LIMHAMN SWEDEN","customerAddress":"NO.18,DR NAIR ROAD, T NAGAR,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1730917800,"product":"VASOPRESSIN USP (VASOPRESSIN,8-L-ARGININE)","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"POLYPEPTIDE LABORATORIES SWEDEN AB","supplierCountry":"DENMARK","foreign_port":"COPENHAGEN","customer":"DR REDDY'S LABORATORIES","customerCountry":"INDIA","quantity":"0.04","actualQuantity":"40","unit":"GMS","unitRateFc":"2850.8","totalValueFC":"114789.2","currency":"USD","unitRateINR":"242171.2","date":"07-Nov-2024","totalValueINR":"9686849","totalValueInUsd":"114789.2","indian_port":"Vizag-EPZ\/SEZ","hs_no":"29371900","bill_no":"1001596","productDescription":"API","marketType":"REGULATED MARKET","country":"DENMARK","selfForZScoreResived":"Pharma Grade","supplierPort":"COPENHAGEN","supplierAddress":"LIMHAMNSVAGEN 108 PO BOX 30089 SE-200 61 LIMHAMN SE","customerAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1744569000,"product":"VASOPRESSIN","address":"OLD NO.1\/63, NEW NO.1\/58 PUDUPAKKAM","city":"","supplier":"BCN PEPTIDES SAU","supplierCountry":"SPAIN","foreign_port":"BARCELONA","customer":"PAR FORMULATIONS PRIVATE LTD","customerCountry":"INDIA","quantity":"0.04","actualQuantity":"40","unit":"GMS","unitRateFc":"1500","totalValueFC":"60699.7","currency":"USD","unitRateINR":"129900","date":"14-Apr-2025","totalValueINR":"5196000","totalValueInUsd":"60699.7","indian_port":"Indore-EPZ\/SEZ","hs_no":"29371900","bill_no":"9473348","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BARCELONA","supplierAddress":"POL IND ELS VINYETS ELS FOGARS II SANT QUINTI DE MEDIONA Barcelona SDNF Spain","customerAddress":"OLD NO.1\/63, NEW NO.1\/58 PUDUPAKKAM"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1747852200,"product":"VASOPRESSIN USP VASOPRESSIN USP","address":"6-3-865\/1\/2, FLAT NO.201,","city":"HYDERABAD, ANDHRA PRADESH","supplier":"POLYPEPTIDE LABORATORIES SWEDEN AB","supplierCountry":"SWEDEN","foreign_port":"MALMO","customer":"GLAND PHARMA LTD","customerCountry":"INDIA","quantity":"0.02","actualQuantity":"17.52","unit":"GMS","unitRateFc":"4118.3","totalValueFC":"73167.4","currency":"USD","unitRateINR":"355816.8","date":"22-May-2025","totalValueINR":"6233910.34","totalValueInUsd":"73167.4","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"2206772","productDescription":"API","marketType":"REGULATED MARKET","country":"SWEDEN","selfForZScoreResived":"Pharma Grade","supplierPort":"MALMO","supplierAddress":"LIMHAMNSVAGEN 108, PO BOX 30089 SE-200 61 LIMHAMN, SWEDEN REG. NO. 556389-7254 SE","customerAddress":"6-3-865\/1\/2, FLAT NO.201,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1750962600,"product":"VASOPRESSIN USP (VASOPRESSIN, 8-L-ARGININE) VASOPRESSIN USP (VASOPRESSIN, 8-L-ARGININE)","address":"MUMBAI CENTRAL,","city":"MUMBAI, MAHARASHTRA.","supplier":"POLYPEPTIDE LABORATORIES SWEDEN AB","supplierCountry":"SWEDEN","foreign_port":"COPENHAGEN","customer":"CIPLA LTD","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.72","unit":"GMS","unitRateFc":"2640.4","totalValueFC":"1939.2","currency":"USD","unitRateINR":"231429.7","date":"27-Jun-2025","totalValueINR":"166629.39","totalValueInUsd":"1939.2","indian_port":"Bombay Air","hs_no":"29371900","bill_no":"2922792","productDescription":"API","marketType":"REGULATED MARKET","country":"SWEDEN","selfForZScoreResived":"Pharma Grade","supplierPort":"COPENHAGEN","supplierAddress":"LIMHAMNSVAGEN 108, PO BOX 30089 SE-200 61 LIMHAMN SWEDEN","customerAddress":"MUMBAI CENTRAL,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1750962600,"product":"VASOPRESSIN USP (VASOPRESSIN, 8-L-ARGININE) VASOPRESSIN USP (VASOPRESSIN, 8-L-ARGININE)","address":"MUMBAI CENTRAL,","city":"MUMBAI, MAHARASHTRA.","supplier":"POLYPEPTIDE LABORATORIES SWEDEN AB","supplierCountry":"SWEDEN","foreign_port":"COPENHAGEN","customer":"CIPLA LTD","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"4","unit":"GMS","unitRateFc":"2640.4","totalValueFC":"10773.5","currency":"USD","unitRateINR":"231429.7","date":"27-Jun-2025","totalValueINR":"925718.85","totalValueInUsd":"10773.5","indian_port":"Bombay Air","hs_no":"29371900","bill_no":"2922792","productDescription":"API","marketType":"REGULATED MARKET","country":"SWEDEN","selfForZScoreResived":"Pharma Grade","supplierPort":"COPENHAGEN","supplierAddress":"LIMHAMNSVAGEN 108, PO BOX 30089 SE-200 61 LIMHAMN SWEDEN","customerAddress":"MUMBAI CENTRAL,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1750962600,"product":"VASOPRESSIN USP (VASOPRESSIN, 8-L-ARGININE) VASOPRESSIN USP (VASOPRESSIN, 8-L-ARGININE)","address":"MUMBAI CENTRAL,","city":"MUMBAI, MAHARASHTRA.","supplier":"POLYPEPTIDE LABORATORIES SWEDEN AB","supplierCountry":"SWEDEN","foreign_port":"COPENHAGEN","customer":"CIPLA LTD","customerCountry":"INDIA","quantity":"0.02","actualQuantity":"19.6","unit":"GMS","unitRateFc":"2640.4","totalValueFC":"52790.2","currency":"USD","unitRateINR":"231429.7","date":"27-Jun-2025","totalValueINR":"4536022.35","totalValueInUsd":"52790.2","indian_port":"Bombay Air","hs_no":"29371900","bill_no":"2922792","productDescription":"API","marketType":"REGULATED MARKET","country":"SWEDEN","selfForZScoreResived":"Pharma Grade","supplierPort":"COPENHAGEN","supplierAddress":"LIMHAMNSVAGEN 108, PO BOX 30089 SE-200 61 LIMHAMN SWEDEN","customerAddress":"MUMBAI CENTRAL,"}]
25-Apr-2022
27-Jun-2025
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

read-more
read-more

Details:

The launch of authorized generic version of Par Pharmaceutical’s VASOSTRICT® (vasopressin injection, USP) Vials in the U.S. Market was approved by the U.S. Food and Drug Administration (USFDA).


Lead Product(s): Arginine Vasopressin,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vasopressin-Generic

Study Phase: Approved FDFProduct Type: Peptide, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 09, 2022

Dr Reddy Company Banner

01

Lead Product(s) : Arginine Vasopressin,Inapplicable

Therapeutic Area : Cardiology/Vascular Diseases

Highest Development Status : Approved FDF

Partner/Sponsor/Collaborator : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : The launch of authorized generic version of Par Pharmaceutical’s VASOSTRICT® (vasopressin injection, USP) Vials in the U.S. Market was approved by the U.S. Food and Drug Administration (USFDA).

Product Name : Vasopressin-Generic

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

February 09, 2022

Dr Reddy Company Banner

Details:

Vasopressin is indicated to increase blood pressure in adults with vasodilatory shock (e.g., post-cardiotomy or sepsis) who remain hypotensive despite fluids and catecholamines.


Lead Product(s): Arginine Vasopressin,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vasostrict-Generic

Study Phase: Approved FDFProduct Type: Peptide, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 26, 2025

blank

02

The Battery Show
Not Confirmed
The Battery Show
Not Confirmed

Details : Vasopressin is indicated to increase blood pressure in adults with vasodilatory shock (e.g., post-cardiotomy or sepsis) who remain hypotensive despite fluids and catecholamines.

Product Name : Vasostrict-Generic

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

August 26, 2025

blank
  • Development Update

Details:

Vasopressin is a Protein drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of unspecified medical condition.


Lead Product(s): Arginine Vasopressin,Inapplicable

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Hormone

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 04, 2025

blank

03

Prisma Health-Upstate

Country
arrow
The Battery Show
Not Confirmed

Prisma Health-Upstate

Country
arrow
The Battery Show
Not Confirmed

Details : Vasopressin is a Protein drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of unspecified medical condition.

Product Name : Undisclosed

Product Type : Hormone

Upfront Cash : Inapplicable

August 04, 2025

blank
  • Development Update

Details:

Vasopressin is a Protein drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Shock, Septic.


Lead Product(s): Arginine Vasopressin,Inapplicable

Therapeutic Area: Trauma (Emergency, Injury, Surgery) Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Hormone

Sponsor: University of Utah

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 22, 2024

blank

04

Intermountain Health

Country
arrow
The Battery Show
Not Confirmed

Intermountain Health

Country
arrow
The Battery Show
Not Confirmed

Details : Vasopressin is a Protein drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Shock, Septic.

Product Name : Undisclosed

Product Type : Hormone

Upfront Cash : Inapplicable

January 22, 2024

blank

Details:

Vasopressin injection is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines and Vasostrict is a RFLD.


Lead Product(s): Arginine Vasopressin,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vasostrict-Generic

Study Phase: Approved FDFProduct Type: Peptide, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 14, 2023

blank

05

The Battery Show
Not Confirmed
The Battery Show
Not Confirmed

Details : Vasopressin injection is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines and Vasostrict is a RFLD.

Product Name : Vasostrict-Generic

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

June 14, 2023

blank

Details:

Vasopressin Injection is indicated to increase blood pressure in adults with vasodilatory shocks, such as due to post-cardiotomy or sepsis, and remain hypotensive despite fluids and catecholamines.


Lead Product(s): Arginine Vasopressin,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vasopressin-Generic

Study Phase: Approved FDFProduct Type: Peptide, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 16, 2022

blank

06

The Battery Show
Not Confirmed
The Battery Show
Not Confirmed

Details : Vasopressin Injection is indicated to increase blood pressure in adults with vasodilatory shocks, such as due to post-cardiotomy or sepsis, and remain hypotensive despite fluids and catecholamines.

Product Name : Vasopressin-Generic

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

August 16, 2022

blank

Details:

Vasopressin injection 1mL is a generic version of the antidiuretic hormone Vasostrict® is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines.


Lead Product(s): Arginine Vasopressin,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vasopressin-Generic

Study Phase: Approved FDFProduct Type: Peptide, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 11, 2022

blank

07

The Battery Show
Not Confirmed
The Battery Show
Not Confirmed

Details : Vasopressin injection 1mL is a generic version of the antidiuretic hormone Vasostrict® is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines.

Product Name : Vasopressin-Generic

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

August 11, 2022

blank

Details:

In August, the U.S. District Court for the District of Delaware held that Eagle’s proposed vasopressin product does not infringe any of the patents Par Pharmaceutical, Inc. et al. asserted against the Company.


Lead Product(s): Arginine Vasopressin,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vasopressin-Generic

Study Phase: Approved FDFProduct Type: Peptide, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 29, 2021

blank

08

The Battery Show
Not Confirmed
The Battery Show
Not Confirmed

Details : In August, the U.S. District Court for the District of Delaware held that Eagle’s proposed vasopressin product does not infringe any of the patents Par Pharmaceutical, Inc. et al. asserted against the Company.

Product Name : Vasopressin-Generic

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

December 29, 2021

blank

Details:

The U.S. District Court for the District of Delaware issue a temporary restraining order and preliminary injunction preventing the launch of Eagle’s recently approved vasopressin product.


Lead Product(s): Arginine Vasopressin,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vasopressin-Generic

Study Phase: Approved FDFProduct Type: Peptide, Unconjugated

Sponsor: Par Pharmaceutical

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 29, 2021

blank

09

The Battery Show
Not Confirmed
The Battery Show
Not Confirmed

Details : The U.S. District Court for the District of Delaware issue a temporary restraining order and preliminary injunction preventing the launch of Eagle’s recently approved vasopressin product.

Product Name : Vasopressin-Generic

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

December 29, 2021

blank

Details:

This approval follows the recent U.S. District Court for the District of Delaware decision holding that Eagle’s proposed vasopressin product does not infringe any of the patents Par Pharmaceutical, Inc. et al. asserted against the Company.


Lead Product(s): Arginine Vasopressin,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vasopressin-Generic

Study Phase: Approved FDFProduct Type: Peptide, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 15, 2021

blank

10

The Battery Show
Not Confirmed
The Battery Show
Not Confirmed

Details : This approval follows the recent U.S. District Court for the District of Delaware decision holding that Eagle’s proposed vasopressin product does not infringe any of the patents Par Pharmaceutical, Inc. et al. asserted against the Company.

Product Name : Vasopressin-Generic

Product Type : Peptide, Unconjugated

Upfront Cash : Inapplicable

December 15, 2021

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

Regulatory Info : RX

Registration Country : USA

VASOPRESSIN

Brand Name : VASOPRESSIN

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 20UNITS/ML (20UNITS/ML)

Packaging :

Approval Date : 2024-05-08

Application Number : 213988

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

02

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

VASOPRESSIN

Brand Name : VASOPRESSIN

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 20UNITS/ML (20UNITS/ML)

Packaging :

Approval Date : 2020-08-03

Application Number : 212593

Regulatory Info : RX

Registration Country : USA

blank

03

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

VASOPRESSIN

Brand Name : VASOPRESSIN

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 20UNITS/ML (20UNITS/ML)

Packaging :

Approval Date : 2022-07-18

Application Number : 211857

Regulatory Info : RX

Registration Country : USA

blank

04

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

VASOPRESSIN

Brand Name : VASOPRESSIN

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 20UNITS/ML (20UNITS/ML)

Packaging :

Approval Date : 2021-12-15

Application Number : 211538

Regulatory Info : RX

Registration Country : USA

blank

05

Pfizer Inc

U.S.A
BioJapan
Not Confirmed
arrow

Pfizer Inc

U.S.A
arrow
BioJapan
Not Confirmed

VASOPRESSIN TANNATE

Brand Name : PITRESSIN TANNATE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 5PRESSOR UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1982-01-01

Application Number : 3402

Regulatory Info : DISCN

Registration Country : USA

blank

06

Country
BioJapan
Not Confirmed
arrow

Country
arrow
BioJapan
Not Confirmed

VASOPRESSIN

Brand Name : VASOSTRICT

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 20UNITS/ML (20UNITS/ML)

Packaging :

Approval Date : 2014-04-17

Application Number : 204485

Regulatory Info : RX

Registration Country : USA

blank

07

Country
BioJapan
Not Confirmed
arrow

Country
arrow
BioJapan
Not Confirmed

VASOPRESSIN

Brand Name : VASOSTRICT

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 200UNITS/10ML (20UNITS/ML)

Packaging :

Approval Date : 2016-12-17

Application Number : 204485

Regulatory Info : RX

Registration Country : USA

blank

08

Country
BioJapan
Not Confirmed
arrow

Country
arrow
BioJapan
Not Confirmed

VASOPRESSIN

Brand Name : VASOSTRICT

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 40UNITS/100ML (0.4UNITS/ML)

Packaging :

Approval Date : 2020-04-15

Application Number : 204485

Regulatory Info : RX

Registration Country : USA

blank

09

Country
BioJapan
Not Confirmed
arrow

Country
arrow
BioJapan
Not Confirmed

VASOPRESSIN

Brand Name : VASOSTRICT

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 60UNITS/100ML (0.6UNITS/ML)

Packaging :

Approval Date : 2020-04-15

Application Number : 204485

Regulatory Info : DISCN

Registration Country : USA

blank

10

Country
BioJapan
Not Confirmed
arrow

Country
arrow
BioJapan
Not Confirmed

VASOPRESSIN

Brand Name : VASOSTRICT

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 20UNITS/100ML (0.2UNITS/ML)

Packaging :

Approval Date : 2021-04-21

Application Number : 204485

Regulatory Info : RX

Registration Country : USA

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more
FDA’s first generic approvals slump 21% in 2024; Novartis’ top seller Entresto, cancer blockbuster Tasigna lead 2024 patent cliff
A watershed moment in the journey of a drug is when it transitions from being a patented, high‐priced innovator product to an affordable generic.Through an inaugural approval, or a “first generic”,  the US Food Drug Administration (FDA) permits a manufacturer to market a generic version of a brand‐name drug — a process that, when successful, grants 180 days of exclusivity to the generic sponsor. This exclusivity is especially valuable when the drug in question is a blockbuster.In FDA’s fiscal year 2024 (i.e. from October 1, 2023 to September 30, 2024), the number of first-time generic drug approvals decreased by 21.3 percent — from 89 in FY 2023 to 70 in FY 2024, the lowest in at least nine years.Lupin emerged as a frontrunner in first generics, increasing its approvals from three in FY 2023 to seven in FY 2024, Apotex and Zydus Lifesciences from four to six, and Dr. Reddy’s from two to four. In contrast, Teva, Amneal, and Sun Pharma experienced a decline.Overall, neurology led the way with 10 approvals, while immunology saw eight, including three approvals in dermatology. Oncology and cardiology/vascular disease saw six approvals each. Ophthalmology saw five while psychiatry, and infectious diseases each contributed four approvals. View First Generic Drug Approvals by FDA in FY 2024 (Free Excel Available)  Novartis’ top seller Entresto, blockbuster Tasigna among six key drugs hit by generic rivalsIn 2024, the tide turned sharply for Novartis as it lost exclusivity for six of its drugs. Among them was its blockbuster Entresto, that has generated US$ 29.2 billion in revenue so far, including US$ 7.8 billion in 2024.A combination of sacubitril and valsartan, Entresto has transformed heart failure management. Entresto was the primary driver of Novartis’ sales growth last year. It was also one of the 10 drugs selected by the Biden administration in 2023 for Medicare price negotiations. Novartis has been fighting a fierce legal battle to protect Entresto from generic competition. In 2024, Entresto’s generic saga reached a crescendo. Alembic Pharmaceuticals, Laurus Labs, and Crystal Pharmaceutical’s generic versions of Entresto received FDA approval in May last year. But the Swiss drugmaker has noted that as of January 2025, there were no Entresto generics available in the US.Novartis’ Tasigna (nilotinib) has been a cornerstone in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). Apotex won approvals for generics of 50 mg, 150 mg, and 200 mg of nilotinib formulations, thereby offering a more affordable option for both adult and pediatric patients. Owing to the generics, Tasigna’s sales fell 10 percent in 2024.Novartis’ Mekinist (trametinib), Votrient (pazopanib), Rydapt (midostaurin), and Promacta (eltrombopag) have long been critical treatments in oncology and hematology. With generic competition hitting these key assets, Novartis is now aggressively forging deals to strengthen its pipeline. View First Generic Drug Approvals by FDA in FY 2024 (Free Excel Available)  FDA clears first generics for Neurocrine’s Ingrezza, Supernus’s Gocovri, ALS drugsIn psychiatry, Neurocrine Biosciences’ Ingrezza (valbenazine) capsules have carved out a niche for themselves as a first-in-class treatment for tardive dyskinesia, a movement disorder that can develop as a side effect of long-term use of antipsychotic meds. Two generics for Ingrezza from India’s Zydus and Lupin bagged FDA approval, as Ingrezza sales topped US$ 2.3 billion last year.Zydus also won first generic approval for Supernus Pharmaceuticals’ Gocovri (amantadine) extended-release capsules, which is a treatment of dyskinesia in Parkinson’s disease patients receiving levodopa-based therapy.Four companies received FDA approvals for their first generics of Mitsubishi Tanabe’s patented drug Radicava (edaravone). These are Dr. Reddy’s Laboratories, Gland Pharma (a Fosun Pharmaceutical subsidiary), Hikma and Long Grove. Radicava is a drug that treats amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. Another treatment for ALS from Italfarmaco — Tiglutik (riluzole) — received a first generic when FDA okayed Alkem Laboratories riluzole oral suspension. The med helps slow disease progression. View First Generic Drug Approvals by FDA in FY 2024 (Free Excel Available)  Pfizer’s Ibrance, Gilead’s Descovy, Lilly’s Olumiant treatment come under generic pressureIn oncology, Synthon Pharmaceuticals launched its generic version of Pfizer’s Ibrance (palbociclib) tablets. Generating sales of US$ 4.4 billion in 2024, this groundbreaking CDK4/6 inhibitor is Pfizer’s best-selling cancer drug. It has transformed treatment for hormone receptor-positive, HER2-negative advanced breast cancer by halting cancer cell division and significantly extending progression-free survival when combined with endocrine therapy.Descovy, a combination of emtricitabine and tenofovir alafenamide, stands as one of the most important therapies in the fight against HIV infection and related conditions. Originally developed by Gilead Sciences, Descovy has played a pivotal role in modern antiretroviral therapy, contributing US$ 2.1 billion to Gilead’s revenue in 2024. Apotex’s first generic approval for Descovy marked its second copycat for a blockbuster drug in 2024. The other generic approval it got its hands on was for Boehringer Ingelheim’s Pradaxa (dabigatran etexilate), a blood thinner that posted sales of € 845 million (US$ 883 million) in 2023.In immunology, Eli Lilly’s Olumiant (baricitinib) has emerged as an important therapy for treating inflammatory conditions such as rheumatoid arthritis. Aurobindo Pharma bagged FDA approval for generic baricitinib tablets.Ipsen’s Somatuline Depot (lanreotide) injection, a treatment for neuroendocrine tumors and endocrine disorders that generated about € 1.07 billion (US$1.1 billion) in 2023 sales, also has a generic now, with Cipla’s subsidiary InvaGen Pharmaceuticals receiving an FDA approval. View First Generic Drug Approvals by FDA in FY 2024 (Free Excel Available) FDA okays copycats for opioid withdrawal med Lucemyra, weight loss drug Qsymia, contraceptive SlyndFDA also demonstrated a focused commitment to addressing two of the nation’s biggest public health concerns — the opioid crisis and obesity. Lucemyra (lofexidine), originally developed by US WorldMeds, is a non-opioid medication indicated for mitigating symptoms associated with acute opioid withdrawal and facilitating the completion of opioid discontinuation treatment. The introduction of Indoco Remedies’ generic version is poised to expand access to this critical therapy by offering a cost-effective alternative for managing substance use disorders.Vivus’ Qsymia (phentermine/topiramate), a chronic weight management therapy, also received a first generic. Actavis’ generic for Qsymia provides a more accessible option to patients striving to lose weight. Actavis is a subsidiary of Teva.FDA also approved Lupin’s first generic version of Insud Pharma’s Slynd—a progestin‑only contraceptive containing 4 mg drospirenone for use by females of reproductive potential to prevent pregnancy. View First Generic Drug Approvals by FDA in FY 2024 (Free Excel Available)  Our viewOver the next two years, several blockbusters such as Novo Nordisk’s Ozempic (semaglutide), AstraZeneca’s Farxiga (dapagliflozin), Bristol Myers Squibb’s Revlimid (lenalidomide) and its Pfizer partnered drug Eliquis (apixaban) stand to lose their patent protection. We expect more patent litigations and some exciting innovations in the generics space.

Impressions: 3735

https://www.pharmacompass.com/radio-compass-blog/fda-s-first-generic-approvals-slump-21-in-2024-novartis-top-seller-entresto-cancer-blockbuster-tasigna-lead-2024-patent-cliff

#PharmaFlow by PHARMACOMPASS
20 Feb 2025

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 113-79-1 / Arginine Vasopressin API manufacturers, exporters & distributors?

Arginine Vasopressin manufacturers, exporters & distributors 1

52

PharmaCompass offers a list of Arginine Vasopressin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Arginine Vasopressin manufacturer or Arginine Vasopressin supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Arginine Vasopressin manufacturer or Arginine Vasopressin supplier.

PharmaCompass also assists you with knowing the Arginine Vasopressin API Price utilized in the formulation of products. Arginine Vasopressin API Price is not always fixed or binding as the Arginine Vasopressin Price is obtained through a variety of data sources. The Arginine Vasopressin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Arginine Vasopressin

Synonyms

113-79-1, Argipressine, Pitressin, Beta-hypophamine, 8-arginine-vasopressin, Argipressin tannate

Cas Number

113-79-1

About Arginine Vasopressin

The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE.

Arginine Vasopressin Manufacturers

A Arginine Vasopressin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Arginine Vasopressin, including repackagers and relabelers. The FDA regulates Arginine Vasopressin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Arginine Vasopressin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Arginine Vasopressin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Arginine Vasopressin Suppliers

A Arginine Vasopressin supplier is an individual or a company that provides Arginine Vasopressin active pharmaceutical ingredient (API) or Arginine Vasopressin finished formulations upon request. The Arginine Vasopressin suppliers may include Arginine Vasopressin API manufacturers, exporters, distributors and traders.

click here to find a list of Arginine Vasopressin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Arginine Vasopressin USDMF

A Arginine Vasopressin DMF (Drug Master File) is a document detailing the whole manufacturing process of Arginine Vasopressin active pharmaceutical ingredient (API) in detail. Different forms of Arginine Vasopressin DMFs exist exist since differing nations have different regulations, such as Arginine Vasopressin USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Arginine Vasopressin DMF submitted to regulatory agencies in the US is known as a USDMF. Arginine Vasopressin USDMF includes data on Arginine Vasopressin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Arginine Vasopressin USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Arginine Vasopressin suppliers with USDMF on PharmaCompass.

Arginine Vasopressin WC

A Arginine Vasopressin written confirmation (Arginine Vasopressin WC) is an official document issued by a regulatory agency to a Arginine Vasopressin manufacturer, verifying that the manufacturing facility of a Arginine Vasopressin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Arginine Vasopressin APIs or Arginine Vasopressin finished pharmaceutical products to another nation, regulatory agencies frequently require a Arginine Vasopressin WC (written confirmation) as part of the regulatory process.

click here to find a list of Arginine Vasopressin suppliers with Written Confirmation (WC) on PharmaCompass.

Arginine Vasopressin NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Arginine Vasopressin as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Arginine Vasopressin API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Arginine Vasopressin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Arginine Vasopressin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Arginine Vasopressin NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Arginine Vasopressin suppliers with NDC on PharmaCompass.

Arginine Vasopressin GMP

Arginine Vasopressin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Arginine Vasopressin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Arginine Vasopressin GMP manufacturer or Arginine Vasopressin GMP API supplier for your needs.

Arginine Vasopressin CoA

A Arginine Vasopressin CoA (Certificate of Analysis) is a formal document that attests to Arginine Vasopressin's compliance with Arginine Vasopressin specifications and serves as a tool for batch-level quality control.

Arginine Vasopressin CoA mostly includes findings from lab analyses of a specific batch. For each Arginine Vasopressin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Arginine Vasopressin may be tested according to a variety of international standards, such as European Pharmacopoeia (Arginine Vasopressin EP), Arginine Vasopressin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Arginine Vasopressin USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty